These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17626704)

  • 1. Trends in abnormal cancer screening results in the United States of America.
    Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
    J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.
    Swan J; Breen N; Coates RJ; Rimer BK; Lee NC
    Cancer; 2003 Mar; 97(6):1528-40. PubMed ID: 12627518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast and cervical cancer screening among Appalachian women.
    Hall HI; Uhler RJ; Coughlin SS; Miller DS
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):137-42. PubMed ID: 11815412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999.
    Coughlin SS; Thompson TD; Hall HI; Logan P; Uhler RJ
    Cancer; 2002 Jun; 94(11):2801-12. PubMed ID: 12115366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mammography and Pap test use from the 1987 and 1992 National Health Interview Surveys: are we closing the gaps?
    Martin LM; Calle EE; Wingo PA; Heath CW
    Am J Prev Med; 1996; 12(2):82-90. PubMed ID: 8777072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
    Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
    Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and correlates of breast and cervical cancer screening among older women.
    Ruchlin HS
    Obstet Gynecol; 1997 Jul; 90(1):16-21. PubMed ID: 9207805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence characteristics after abnormal screening results between mammogram and Papanicolaou test groups.
    Fang SY; Shu BC
    Cancer Nurs; 2009; 32(6):437-45. PubMed ID: 19816157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-level differences in breast and cervical cancer screening by disability status: United States, 2008.
    Armour BS; Thierry JM; Wolf LA
    Womens Health Issues; 2009; 19(6):406-14. PubMed ID: 19879454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women.
    Echeverria SE; Carrasquillo O
    Med Care; 2006 Aug; 44(8):788-92. PubMed ID: 16862042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
    Hewitt M; Devesa SS; Breen N
    Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processes of care in cervical and breast cancer screening and follow-up--the importance of communication.
    Zapka JG; Puleo E; Taplin SH; Goins KV; Ulcickas Yood M; Mouchawar J; Somkin C; Manos MM
    Prev Med; 2004 Jul; 39(1):81-90. PubMed ID: 15207989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women.
    Buki LP; Jamison J; Anderson CJ; Cuadra AM
    Cancer; 2007 Oct; 110(7):1578-85. PubMed ID: 17696119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
    Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and cervical cancer screening in Spain and predictors of adherence.
    Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
    Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.